Abstract
One of the important strategies and tactics in the search for new drugs still constists in the empirical approach i.e. the systematic screening of pure compounds or plant extracts in order to find useful lead compounds.
Structure-activity relationship studies of these lead compounds combined with computer-graphic model building can end up with promising candidate drugs having optimal activity and bioavailability, an acceptable therapeutic index and fewer side effects.
One of the key steps in the implementation of this rational serendipity methodology is the development of screening bioassays, which are adaptable to the testing of plant extracts, which can be highly colored, tarry, water insoluble and chemically very complex.
Several general screening bioassays including primary and broad bioassays and different specialized screening bioassays including lower organisms, isolated subcellular systems, isolated cellular systems, isolated organs of vertebrates and whole animals are systematically reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Suffness, M. and Pezzuto, J.M. (1991) Assays related to cancer drug discovery in K. Hostettmann (ed.), Methods in Plant Biochemistry, Vol. 6, Assays for Bioactivity, Academic Press,London, 71–
Vanden Berghe, D.A. and Vlietinck, A.J. (1991) Screening for antibacterial and antiviral agents in K. Hostettmann (ed.), Methods in Plant Biochemistry, Vol. 6, Assays for Bioactivity, Academic Press, London, 47–69.
Cordell, G.A. (1995) Changing strategies in natural products chemistry, Phytochemistry, 40, 1585–1612
Ghisalberti, E.L. (1993) Detection and isolation of bioactive natural products in S.M. Colegate and R.J. Molyneux (eds.), Bioactive natural products: detection, isolation and structural determination, CRC Press, Boca Raton, 9–57.
Hostettmann K., Marston, A. and Wolfender, J.L. (1995) in K. Hostettmann, A. Marston, M. Maillard and M. Hamburger (eds.), Proceedings of the Phytochemical Society of Europe, Phytochemistry of Plants used in Traditional Medicine, Clarendon Press, Oxford, 17–45.
Vogel, H.G. and Vogel, W.H. (eds. (1997) Drug discovery and evaluation: pharmacological assays, Springer Verlag, Berlin, 1–755.
Williamson, G.M., Okpako, D.T. and Evans, F.J. (1996) in Pharmacological Methods in Phytotherapy Research, Vol. I: Selection, Preparation and Pharmacological Evaluation of Plant Material, John Wiley & Sons, Chichester, 1–228.
Malone, M.K. (1983) The pharmacological evaluation of natural products: general and specific approaches to screening ethnopharmaceuticals, J. Ethnopharmacol., 8, 127–147.
Samuelsson, G. (1991) Assays for pharmacological activity: non-specific assays in K. Hostettmann (ed.), Methods in Plant Biochemistry, Vol. 6, Assays for Bioactivity, Academic Press, London, 261–280.
Vlietinck, A.J., Vanden Berghe, D.A. and Laekeman, G.M. (1991) in Proceedings of the International Symposium on Innovations in Pharmaceutical Sciences and Technology, Shri B.V. Patel Perd Centre, Ahmedabad, 27. 10-29. 10.1990, Vol. I, 150–182.
McLaughlin, J.C. (1991) Crown gall tumours on potato discs and brine shrimp lethality: two simple bioassays for higher plant screening in K. Hostettmann (ed.), Methods in Biochemistry, Vol. 6, Assays for Bioactivity, Academic Press, London, 1–32
Meyer, B.N., Ferrigni, N.R., Putmann, J.E., Jacobson, L.B., Nichols, D.E. and McLaughlin, J.L. (1982) Brine shrimp: a convenient general bioassay for active plant constituents, Planta Med., 45, 31–34.
Ferrigni, N.R., Putman, J.E., Anderson B., Jacobson, L.B., Nichols, D.E., Moore, D.S., McLaughlin, J.L., Powell, R.G. and Smith, C.R. Jr. (1982) Modification and evaluation of the potato disc assay and antitumour screening of Euphorbiacaea seeds, J. Nat. Prods., 45, 679–686.
Kubo, L. (1989) Effects of a marine algal constituent on the growth of lettuce and rice seedlings, Pure Appl. Chem., 61, 373–376.
Vlietinck, A.J. and Vanden Berghe, D.A. (1991) Can ethnopharmacology contribute to the development of antiviral drugs? J. Ethnopharmacol., 32, 141–153.
Hu, J.M. and Hsiung, CD. (1989) Evaluation of new antiviral agents. I. In vitro, perspectives, Antiviral Res., 11, 217–232.
Lednicer, D. and Narayanan, V.L. (1993) Acquisition and screening of natural products as potential anticancer andantiviral agents in S.M. Colegate and RJ. Molyneux (eds.) Bioactive natural products: detection, isolation and structural determination, CRC Press, Boca Raton, 159–172.
De Clerq, E. (1995) Antiviral therapy for human immunodeficiency virus infections, Clin. Microb. Rev., 8, 200–239
Galasso, G.J. (1989) Antiviral agents. Why not a “penicillin” for usual infections? In E. De Clercq and R.T. Walker (eds.) Targets for the design of antiviral agents. Plenum Publishing Cooperation, New York,...
Sidwell, R.W. (1986) Determination of antiviral activity, Drugs and Pharmaceutical Sciences, 27, 433–480.
Philippson, J.D. (1991) Assays for antimalarial and amoebicidal activities in K. Hostettmann (ed.). Methods in Plant Biochemistry, Vol. 6 Assays for Bioactivity, Academic Press, London, 135–152.
Philippson, J.D. (1995) A matter of some sensitivity, Phytochemistry, 38, 1319–1343.
Baldé, A.M., Van Marck, E.A., Kestens L., Gigase, PL. and Vlietinck, A.J. (1989) Schistosomicidal effects of Pavetta owariensis, and Harrisonia abyssinica, in mice infected with Schistosoma mansoni, Planta Med., 55, 41–43.
Sweetnam, P.M., Caldwell L., Lancaster J., Bauer, L. Jr., McMillan B., Kinner, W.J. and Price, C.H. (1993), The role of receptor binding in drug discovery, J. Nat. Prods., 56, 441–455.
Zhu M., Greengrass, P.M. and Philippson, J.D. (1996) Application of radioligand receptor binding assays in the search for CNS active principles from Chinese medicinal plants, J. Ethnopharmacol, 54, 153–164.
Hasrat, J.A., De Backer, J.-P, Vauquelin, G. and Vlietinck, A.J. (1997) Medicinal plants in Suriname: screening of plant extracts for receptorbinding activity, Phytomedicine, 4, 59–65.
Hasrat, J.A., Pieters L., Claeys, M. and Vlietinck, A. (1997) Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis, J. Nat. Prods., 60, 638–641.
Hasrat, J.A., Pieters L., De Backer, J.-P, Vauquelin, G. and Vlietinck, A. (1997) Screening of medicinal plants from Suriname for 5-HT1A ligands: bioactive isoquinoline alkaloids from the fruits of Annonamuricat, Phytomedicine, 4, 133–140.
Irth H., Oosterkamp, A.J., Tjaden, U.R. and van der Greef, J. (1995) Strategies for on-line coupling of immunoassays to high-performance liquid chromatography, Trends Anal. Chem., 14, 355–361.
Oosterkamp, A.J., Villaverde Herraiz, M.T., Irth H., Tjaden, U.R. and van der Greef, J. (1996) Reversedphase liquid chromatography coupled on-line to receptor-affinity detection based on the human estrogen receptor, Anal. Chem., 68, 1201.
Geron, G.T., Greenberg, M.M., McDonald, A.M., Schumacher, A.M. and Abbott, B.J. (1972) Protocols for screening chemical agents and natural products against animal tumours and other biological systems, Cancer Chemother. Rep. (Part 3), 3, 1–14.
Boyd, M.R. (1989) Status of the NCI preclinical antitumor drug discovery screen. Principles and Practice of Oncology, PPO Updates, Vol. 3(10), 1–12.
Boyd, M.R. and Paull, K.D. (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen, Drug Developm. Res., 34, 91–109.
Verhagen, H. and Feron, V.J. (994) Cancer prevention by natural food constituents. The lessons of toxicology transposed to antigenotoxicity and anticarcinogenicity in H. Kozlowska, J. Fornal and Z. Zdunézyck (eds.) Bioactive substances in food of plant origin, 2, 463–478.
Wattenbergh, L. W. (1992) Inhibition of carcinogenesis by minor dietary constituents, Cancer Res. (suppl.), 52, 2085s–2091s.
Hartman, PE. and Shankel, D.M. (1990) Antimutagens and anticarcinogens: a survey of putative interceptor moles, Environm.. Molec. Mutagen., 15, 145–182.
Waters, M.D., Stack, H.F., Jackson, M.A., Brockman, U.E., De Flora, S. (1996) Activity profiles of antimutagens: in vitro, and in vivo, data, Mutat. Res., 350, 109–129.
Kehrer, J.P. and Smith, C.V. (1994) Free radicals in biology: sources, reactivities and roles in the ethiology of human diseases, in B. Frei (ed)., Natural oxidants in human health and diseases, Academic Press, New York, 2, 25–62.
Halliwell B., Gutteridge, J.M.C. and Cross, C.E. (1992) Free radicals, antioxidants and human disease: where are we now? J. Lab. Clin. Med., 598–620.
Wagner, H. and Jurcic, K. (1991) Assays for immunomodulation and effects in mediators of inflammation, in K. Hostettmann (ed.), Methods in Plant Biochemistry, Vol. 6, Assays for Bioactivity, Academic Press, London, 195–217.
Labadie, R.P. (1993) Immunomodulatory compounds, in S.M.Colegate and R.J. Molyneux, Bioactive natural products: detection, isolation and structure determination, CRC Press, Boca Raton, 14, 279–317.
Lasure A., Van Poel B., Cimanga K., Pieters L., Vanden Berghe, D. and Vlietinck, A.J. (1994) Modulation of the complement system by flavonoids, Pharm. Pharmacol. Lett., 4, 32–35.
Cimanga K., De Bruyne T., Lasure A., Van Poel B., Pieters L., Vanden Berghe, D. and Vlietinck, A. (1995) In vitro, anticomplementary activity of constituents from Morinda morindoides, J. Nat. Prod., 58, 372–378.
Rasheed A., Laekeman, G.M., Vlietinck, A.J., Janssen J., Hatfield G., Tott¿)¿ J. and Herman, A.G. (1984) Pharmacological influence of nutmeg and nutmeg constituents on rabbit platelet-function, Planta Med., 50, 222–226.
Laekeman, G.M., De Clerck F., Vlietinck, A.J. and Herman, A.G. (1985) Vernolepin: an anti-platelet compound of natural origin, Naunyn-Schiemdebergs Arch. Pharmacol., 331, 108–113.
Vanden Berghe, D.A., Yang, Q.R., Totté, J. and Vlietinck, A.J. (1993) Specific stimulation of human endothelial cells by Triticum vulgare, extract and its biologically active fraction, Phytother. Res., 7, 172–178.
Pieters L., De Bruyne T., Claeys M., Vlietinck A., Calomme, M. and Vanden Berghe, D. (1993) Isolation of a dihydrobenzofuran lignan from South American Dragon’s blood (Croton, spp.) as an inhibitor of cell proliferation, J. Nat. Prod., 56, 899–906.
Laekeman, G.M., Mertens J., Totté, J., Bult H., Vlietinck, A.J. and. Herman, A.G. (1983) Isolation and pharmacological characterization of vernolepin, J. Nat. Prod ff., 46, 161–169.
Bakana P., Laekeman, G.M., Totté, J., Herman, A.G. and Vlietinck, A.J. (1985) Stereochemical considerations in relation to the pharmacological activity of Pterotabernaff alkaloids, J. Nat. Prod., 48, 766–771.
Laekeman, G.M., Claeys M., Rwangabo, P.C., Herman, A.G. and Vlietinck, A.J. (1986) Cardiovascular effects of 3-methylquercetin, Planta Med., no. 6, 433–437.
Üstünes L., Claeys M., Laekeman G., Herman, A.G., Vlietinck, A.J. and Özer, A. (1985) Isolation and identification of two isomeric trihydroxy octadecenoic acids with prostaglandin E-like activity from onion bulbs (Allium cepa), Prostaglandins, 29, 847–865.
Üstünes, L., Özer A., Laekeman, G.M., Corthout J., Pieters, L.A.C., Baeten W., Herman, A.G., Claeys, M. and Vlietinck, A.J. (1991) Clinical characterization and pharmacological activity of nazlinin, a novel indole alkaloid from Nitraria schoberi, J. Nat. Prod., 54, 959–966.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Vlietinck, A.J. (1999). Screening Methods for Detection and Evaluation of Biological Activities of Plant Preparations. In: Bohlin, L., Bruhn, J.G. (eds) Bioassay Methods in Natural Product Research and Drug Development. Proceedings of the Phytochemical Society of Europe, vol 43. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4810-8_4
Download citation
DOI: https://doi.org/10.1007/978-94-011-4810-8_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6019-6
Online ISBN: 978-94-011-4810-8
eBook Packages: Springer Book Archive